Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 54,73
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 55,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 52,63
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing 2021-04-06, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: Chiron Media, Wallingford, Regno Unito
EUR 50,57
Quantità: 10 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 52,62
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 59,76
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: moluna, Greven, Germania
EUR 45,45
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: preigu, Osnabrück, Germania
EUR 47,85
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. How to Develop Method for Pulmonary Dry Powder Inhalers | Method Development of Inhalers | Keyur Bhatt (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2021 | LAP LAMBERT Academic Publishing | EAN 9786203840001 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: PBShop.store US, Wood Dale, IL, U.S.A.
EUR 57,09
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 54,48
Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Apr 2021, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 54,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Dry powder inhalers (DPIs) are the system in which devices used to administrate a dry powder formulation of an active drug is delivered for local or systemic effect via the pulmonary route. DPIs have several advantages over other methods of pulmonary drug delivery, for example, direct delivery of the drug into the deep lungs utilizing the patient's respiration and are increasingly being explored as a mechanism for the delivery of systemic drugs. Successful delivery of drugs into the deep lungs depends on the integration between powder formulations and the device performance. Development requires that current DPIs demonstrate in vitro performance and reliability. However, questions remain about the ability to interchange DPIs and the effects of different clinical states and patient characteristics. 108 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Apr 2021, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 54,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Dry powder inhalers (DPIs) are the system in which devices used to administrate a dry powder formulation of an active drug is delivered for local or systemic effect via the pulmonary route. DPIs have several advantages over other methods of pulmonary drug delivery, for example, direct delivery of the drug into the deep lungs utilizing the patient's respiration and are increasingly being explored as a mechanism for the delivery of systemic drugs. Successful delivery of drugs into the deep lungs depends on the integration between powder formulations and the device performance. Development requires that current DPIs demonstrate in vitro performance and reliability. However, questions remain about the ability to interchange DPIs and the effects of different clinical states and patient characteristics.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 108 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2021
ISBN 10: 6203840009 ISBN 13: 9786203840001
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 55,56
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Dry powder inhalers (DPIs) are the system in which devices used to administrate a dry powder formulation of an active drug is delivered for local or systemic effect via the pulmonary route. DPIs have several advantages over other methods of pulmonary drug delivery, for example, direct delivery of the drug into the deep lungs utilizing the patient's respiration and are increasingly being explored as a mechanism for the delivery of systemic drugs. Successful delivery of drugs into the deep lungs depends on the integration between powder formulations and the device performance. Development requires that current DPIs demonstrate in vitro performance and reliability. However, questions remain about the ability to interchange DPIs and the effects of different clinical states and patient characteristics.